The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myelomaAndrew Spencer, Christine Chen, Deborah A. Smith et al.|Blood|2014Cited by 140
A Phase I Study of the Metal Ionophore Clioquinol in Patients With Advanced Hematologic MalignanciesAaron D. Schimmer, Mark D. Minden, Yulia Jitkova et al.|Clinical Lymphoma Myeloma & Leukemia|2012Cited by 43